Companies: 49,246 Total Market Cap: 132391015460924.41

Jerusalem Pharmaceuticals Co. Ltd.

PEX-JPH
Pharmaceutical Preparations
Rank #26739
Market Cap 69.31 M
Volume 5,255
Price 5.43
Change (%) 0.52%
Country or region Palestine Palestine

Jerusalem Pharmaceuticals Co. Ltd.'s latest marketcap:

69.31 M

As of 05/20/2025, Jerusalem Pharmaceuticals Co. Ltd.'s market capitalization has reached $69.31 M. According to our data, Jerusalem Pharmaceuticals Co. Ltd. is the 26739th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 69.31 M
Revenue (ttm) 41.88 M
Net Income (ttm) 6.87 M
Shares Out 18 M
EPS (ttm) 0.38
Forward PE 0.00
Ex-Dividend Date 04/30/2025
Earnings Date 05/14/2025
Market Cap Chart
Data Updated: 05/20/2025

Jerusalem Pharmaceuticals Co. Ltd.'s yearly market capitalization.

Jerusalem Pharmaceuticals Co. Ltd. has seen its market value grow from د.أ35.35 M to د.أ49.13 M since 2020, representing a total increase of 38.97% and an annual compound growth rate (CAGR) of 7.79%.
Date Market Cap Change (%)
05/20/2025 د.أ49.13 M -3.53%
12/24/2024 د.أ48.95 M 0.78%
12/31/2023 د.أ48.57 M 15.89%
12/29/2022 د.أ41.91 M 16.1%
12/23/2021 د.أ36.10 M 2.12%
12/31/2020 د.أ35.35 M

Company Profile

About Jerusalem Pharmaceuticals Co. Ltd.

Jerusalem Pharmaceuticals Co. Ltd. is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of a diverse range of healthcare products. Established in 1969 and headquartered in Ramallah, Palestinian Authority, the company serves markets across Palestine, the Middle East, North Africa, and internationally.

Product Portfolio

The company offers a comprehensive selection of pharmaceutical and wellness products, including:

  • Over-the-counter (OTC) medications
  • Prescription pharmaceuticals
  • Nutritional supplements

Manufacturing Capabilities

Jerusalem Pharmaceuticals produces approximately 300 pharmaceutical products in various dosage forms, such as:

  • Tablets & capsules
  • Sterile injectables
  • Suspensions & syrups
  • Powders, suppositories, and ovules
  • Creams, ointments, and topical solutions
  • Ear and nose drops

Additional Product Lines

Beyond pharmaceuticals, the company also manufactures:

  • Detergents & cleaning products
  • Cosmetics & personal hygiene items
  • Veterinary medicines
  • Agricultural products
Frequently Asked Questions

As of 05/20/2025, Jerusalem Pharmaceuticals Co. Ltd. (including the parent company, if applicable) has an estimated market capitalization of $69.31 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Jerusalem Pharmaceuticals Co. Ltd. global market capitalization ranking is approximately 26739 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Palestine
Founded 1969
IPO Date n/a
Employees 531
CEO Mohammed Mahmoud Masrouji
Sector
Industry Pharmaceutical Preparations
Address PO BOX 3570
Ramallah
Palestinian Authority
Website https://www.jepharm.ps
People Also Watch
Ipsen S.A.
138.21 0.52%
Krka, d. d.
209.75 0.52%
BUD-RICHTER
29.12 0.52%
Hugel
244.93 0.52%